GELS
Gelteq Ltd
$0.58
-0.02 (-2.84%)
At close · Jul 7
Market Cap
$6.22M
Shares
10,711,059
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.58
Open$0.61
Day$0.57–0.61
52W$0.39–2.02
Avg vol 30d6.6M
Short int426K · 4.0% float · 1.0d
Short vol15%
DataOct 2024–Jul 2026
Equibles Rating
blended score · not investment advice
Overall
Strong Sell
SellHoldBuy
Technical
Strong Sell
Momentum
Weak
Sentiment
Neutral
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 16.9 · calm
Equity put/call 0.86
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−34%
below
Price vs 50-day avg
−8%
below
RSI (14)
45
neutral
MACD trend
Negative
52-week position
12%
near low
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+17%
trailing
6-month return
−26%
trailing
YTD return
−27%
this year
Relative strength
−33%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $1 › 200d $1 — 200d above 50d
Institutional flow
Accumulating
+67% holders QoQ · +3 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
3.98% of float · ▲ +453.2% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
5 holders — mid 1-yr range
Squeeze score
57
elevated · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
241%
annualized · 1-yr
Max drawdown
−80%
past year
ATR
26.6%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Up next
FQ1-27 quarter ends
~Sep 30, 2026
Est
Technicals
trend & momentum for long-term holders Strong Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−34%
Bearish
Price vs 50-day avg
−8%
Bearish
RSI (14)
45
Neutral
MACD trend
Negative
Bearish
52-week position
12%
Bearish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $1 › 200d $1 — 200d above 50d
Institutional flow
Accumulating
+67% holders QoQ · +3 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
3.98% of float · ▲ +453.2% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
5 holders — mid 1-yr range
Price context
position in its 52-week range
52-wk low $0
Now $1 · 12%
52-wk high $2
vs 200-day avg -34%
vs 50-day avg -8%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Drug Manufacturers - Specialty & Generic — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
GELS
this stock
Gelteq Ltd
|
$6.22M | -27.4% | — | — | 4.0% |
|
TAK
Takeda Pharmaceutical Co Ltd
|
$53.49B | +7.4% | — | — | 0.2% |
|
GALDY
Galderma Group AG/ADR
|
$51.02B | +4.9% | — | — | 0.0% |
|
JHPCY
Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR
|
$45.13B | — | — | — | 0.0% |
|
HLN
Haleon plc
|
$42.94B | -3.6% | — | — | 0.3% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Institutional Holders
Reducing
Holders
5
- % held
- 0.6%
- Net QoQ
- -22.9K sh
- Top holder
- WEDBUSH SECURITIES INC
Held
Float
Short & Settlement
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| GELS | -11.8% | +16.9% | -25.8% | -13.3% | -27.4% |
| SPY | +0.9% | +1.4% | +7.6% | +0.1% | +9.7% |
| vs SPY | -12.7% | +15.5% | -33.4% | -13.4% | -37.0% |